ANTIBODIES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Antibodies Market - Overview An antibody (Ab), also known as an immunoglobulin (Ig), is secreted by B cells of the adaptive immune system, mostly by differentiated B cells called plasma cells. Antibodies are used in the treatment of various cancers and other diseases such as rheumatoid arthritis and psoriasis. Statistics: The global Antibodies Market is estimated to account for US$ 147,385.1 Mn in terms of value and is expected to reach US$ 384,011.6 Mn by the end of 2027. Global Antibodies Market: Drivers Increasing demand for antibody-drug conjugates (ADCs) is expected to propel growth of the global antibodies market over the forecast period. ADCs use monoclonal antibodies to specifically bind tumour-associated target antigens and deliver a highly potent cytotoxic agent. This has led to increasing adoption of ADCs for the treatment of cancer. Global Antibodies Market: Opportunities Major players in the market can focus on expanding their presence in Africa, especially with focus on launching generic products. This is owing to high incidence of cancer in the region and regulatory reforms for development and registration of biosimilars. For instance, according to the World Health Organization. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/antibodies-market-2629 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways: The monoclonal antibodies sub segment in the drug type segment in global antibodies market was valued at US$ 124,936.8 Mn in 2018 and is expected to reach US$ 367,264.6 Mn by 2027 at a CAGR of 12.6% during the forecast period. Increasing approval and robust pipeline of novel human monoclonal antibodies is expected to aid in the segment growth. In the years 2014-2018, highest number of monoclonal antibodies (i.e. 6) were approved in the U.S. in 2018 and Europe witnessed highest number of monoclonal antibodies (i.e. 8) approval in 2017. Out of 8 approvals in Europe in 2017, 4 were biosimilar versions of Humira (adalimumab). The cancer sub segment in disease indication segment held dominant position in the global antibodies market in 2018, accounting for 54.8% share in terms of value. High prevalence of cancer and frequent approval and launch of novel monoclonal antibodies in the market is expected to significantly drive growth of the cancer segment over the forecast period. The hospitals sub segment in end user segment held dominant position in the global antibodies market in 2018, accounting for 86.4% share in terms of value, followed by long term care facilities, and research institutes, respectively. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2629 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Regulations Europe In the European Union (EU), biological products including therapeutic monoclonal antibodies are subject to the approval from European Medicines Agency (EMA) through centralized procedure Manufacturers of all the biological products are required to get the marketing authorization application (MAA) prior to the marketing of any biological drugs in the European market Centralized MAA for biological products obtained under Regulation (EC) No 726/2004 of the European Parliament And Of The Council allows the applicant to market their product in all the 27 member countries For biological drugs which have got orphan drug designation should obtain MAA as per Regulation (EC) No 141/2000 of the European Parliament And Of The Council
Global Antibodies Market: Competitive Landscape Major players operating in the global antibodies market include, Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2629 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved